Resorcinol: support the adequate SVHC identification of this known endocrine disruptor for health
PDF | 405 kb
PDF | 405 kb
At the REACH Committee meeting scheduled on 22-23 September, Member States will discuss and
possibly vote on a European Commission proposal to identify the substance Resorcinol as a
substance of very high concern (SVHC) due to endocrine disrupting properties for health under the
REACH regulation (article 57(f)).
Eight NGOs are calling on EU Member States to support this proposed identification in order to ensure that public authorities, actors in the supply chain, workers, and citizens have adequate knowledge on the hazardous properties of the substance.
Resorcinol impacts the functioning of the thyroid system, which is essential for brain development,
in particular for unborn children. Exposure to Resorcinol has been shown to affect thyroid hormone
levels in experimental rodent studies and to lead to a series of severe developmental effects related
to such hormone level changes in humans as documented by case reports, including hypothyroidism,
goiter, neurological impacts in the child. The latter effects can be considered irreversible because
they strongly affect the wellbeing and quality of life of an individual over the long-term.
This letter was sent to:
Krista Mikkonen, Finland's Minister of the Environment and Climate Change
Mika Lintilä, Finland's Minister for Economic Affairs
Hanna Sarkkinen, Finland's Minister for Social Affairs and Health